QBI Enterprises
Clinical-stage Pharmaceutical Company
Health Tech & Life Sciences
Non Active, May 2022 ceased to operate
Company Overview
Snapshot
Founded in March 1993 by Daniel Zurr, Ph.D., QBI Enterprises operated with 11–50 employees. The company ceased operations in May 2022.
Business overview
QBI Enterprises is a clinical-stage pharmaceutical company focused on drug development. The company operates a fully integrated drug development platform that covers therapeutic target identification through to drug development, specializing in areas such as antibodies, molecular biology, generic drugs, proteins, and biological therapy. It serves the pharmaceutical sector within the Health Tech & Life Sciences industry, with a market presence in India, the United States, and China.
Log in to access full profile ›Company Intelligence Q&A
- What is QBI Enterprises' primary focus?
- QBI Enterprises is a clinical-stage pharmaceutical company with a fully integrated drug development platform, spanning from therapeutic target identification to drug development.
- When was QBI Enterprises founded?
- QBI Enterprises was founded in March 1993.
- Who was a co-founder of QBI Enterprises?
- Daniel Zurr, Ph.D. was a co-founder of QBI Enterprises.
- What is the operational status of QBI Enterprises?
- QBI Enterprises is non-active and ceased to operate in May 2022.
- In which countries did QBI Enterprises have a market presence?
- QBI Enterprises had a market presence in India, the United States, and China.